In none of the studies were women treated with antiretrovirals other than AZT, and viral load measurements were not reported. The widespread use of this strategy in developing countries raises further concerns. It seems very possible, however, that a subgroup of women, who for various reasons are unable to achieve appropriate reductions in viral burden, may reasonably consider the option of operative delivery.
More study is needed.
The Johns Hopkins University on behalf of its Division of Infectious Diseases and AIDS Service. All rights reserved. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.